Top Biotech Companies (3,709)
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility....
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions worldwide have used GenScript’s premier, convenient, and reliable products and services. GenScript currently has over 5,000 employees globally, 33% holding master’s...
GenScript's Top Stability & Growth Strengths
Strong Revenue Growth: Recent periods show strong top-line expansion across 2023, 2024, and H1 2025, with momentum supported by gains in Life Science Services, CDMO, and industrial synthetic biology. Forward-looking commentary indicates continued growth expectations for core segments.
Investor Backing & Capital Strength: The company reports a sizable cash position and undertook substantial investments in manufacturing and commercial capabilities in the United States and Europe. This financial strength underpins capacity expansion and supports strategic execution.
Diversified Revenue Streams: Multiple business units contribute to performance, including Life Science Services, ProBio CDMO, and industrial synthetic biology, alongside growth in a commercial cell therapy franchise. A developing synthetic biology pipeline with near-term product launches further broadens sources of revenue.
Bactobio is a London-based biotechnology startup developing next-generation antimicrobials to address antimicrobial resistance in healthcare and agriculture. Its deep-tech platform combines synthetic biology, next-generation sequencing, machine learning, and multiomics to cultivate previously unculturable microbes and discover novel chemicals. The company is pursuing novel antibiotics and biodegradable fungicides intended to bypass resistance, support commercial products, and help stabilize global food security.
At Artiva, our mission is to deliver to cancer patients highly effective cellular immunotherapies that are also safe and immediately accessible. Towards this end, Artiva is advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, including CAR-NK cell therapies, that leverage the company’s unique manufacturing and engineering capabilities. Artiva is headquartered in San Diego.
binx health is a health technology company dedicated to expanding convenient and equitable access to healthcare. The company specializes in point-of-care molecular diagnostics, specifically with its FDA-cleared, CLIA-waived binx io platform, which enables rapid diagnosis and treatment of chlamydia and gonorrhea infections in about 30 minutes. Its mission is to improve community health outcomes by providing high-quality diagnostic solutions tailored...
Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care. More than 800,000 patients across the world are impacted by Ortho’s tests each day. Because Every Test is a Life, Ortho provides hospitals, hospital networks, clinical laboratories and blood banks around the world with innovative technology and tools to...
Ortho Clinical Diagnostics's Top Stability & Growth Strengths
Strong Market Position & Advantage: Filings and investor materials position the company as the global leader in transfusion medicine/immunohematology, supported by long‑standing platforms and a large reagent installed base. This entrenched footprint drives durable recurring demand across hospital and donor centers.
Diversified Revenue Streams: The combined portfolio spans core‑lab chemistry and immunoassay, molecular, and point‑of‑care, providing revenue across lab and near‑patient settings even if not the overall market leader. Management highlights non‑respiratory recurring revenues within Labs, Immunohematology, and Cardiac as steady contributors.
Cost & Operational Efficiency: Post‑merger integration has delivered cost and portfolio synergies alongside expanding adjusted margins. These actions indicate improving operational leverage despite mixed top‑line trends.
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in...
Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building differentiated capabilities across the spectrum of cell and gene therapy. Three aspirations drive Sana as we look to discover...
Nosis Bio is an AI-native biotechnology company pioneering receptor-targeted RNA therapeutics. They leverage deep learning and novel biochemistry to develop cell-specific RNA medicines, aiming to solve drug delivery challenges and create programmable therapeutics.
Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, our approach combines unprecedented computational power with leading-edge experimental approaches across the fields of structural biology, biophysics, chemistry and biology. By applying these insights, we believe we have a differentiated approach...
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high-quality data, increase workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietary approach to improving the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry,...
TIENS Group is a global multinational conglomerate founded in 1995 by Li Jinyuan in Tianjin, China. The company specializes in biotechnology, health management, and wellness, operating in over 190 countries. It offers a wide range of dietary supplements, healthcare equipment, and beauty products, aiming to improve global health by integrating nature with modern science and technology to provide a better...
AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases. AIRNA’s experienced team is aiming to advance a pipeline of RNA editing therapeutics driven by its powerful and flexible RNA editing platform, RESTORE+.
Morgridge Institute for Research is a nonprofit biomedical research institute affiliated with the University of Wisconsin–Madison. It pursues fearless, curiosity-driven science to deepen understanding of biology and advance human health. The institute supports interdisciplinary investigators, develops transformational tools, and connects basic research with translational outcomes, while also fostering scientific curiosity, education, and public engagement through its partnership with the university...
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis is applying insights into the genetic mutations that drive excitation-inhibition imbalance in diseases to select biological targets for rare and more prevalent neurological disorders. We share a common vision of reshaping the human condition into...
Dyno Therapeutics is a Cambridge based, VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies
Repertoire Immune Medicines is a biotechnology company dedicated to creating treatments for diseases based on the power of the human T cell repertoire to eliminate cancer cells, target pathogens, and regulate immune function in autoimmune disease. The company’s proprietary DECODE™ platform provides a comprehensive understanding of the interactions between T cell receptors and their antigens in disease. DECODE uniquely elucidates the...
GlycoEra is a biotechnology company that develops bifunctional biologics and extracellular protein degraders for the treatment of autoimmune diseases. The company focuses on selectively targeting and removing circulating proteins, such as autoantibodies, to treat immune-driven disorders. Their precision immunology platform aims to provide deep and selective degradation of disease-causing proteins while avoiding the broad immunosuppressive effects typical of existing therapies.
Orion is a globally operating Nordic pharmaceutical company and builder of well-being. Rooted in Nordic values of trust and openness, the company focuses on developing treatments and conducting research to empower people to live their lives to the fullest. Operating in over 35 countries, Orion drives innovation in healthcare to improve health outcomes for millions of people worldwide.












.png)



















